Zim Laboratories Intrinsic Value
Zim Laboratories (ZIMLAB) median intrinsic value is ₹102.86 from 4 valuation models (range ₹65–₹149), vs current price ₹85.34 — +20.5% upside (Trading Below Calculated Value), margin of safety 17.0%. For current market price and key ratios, visit ZIMLAB stock live price.
ZIMLAB Valuation Methods Summary — DCF, Graham Number & P/E
Zim Laboratories intrinsic value across 4 models vs current price ₹85.34 — upside/downside and value range per method. Also explore ZIMLAB price trends to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹102.86 | ₹92.57 - ₹113.15 | +20.5% | Book Value/Share: ₹51.43, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹148.57 | ₹133.71 - ₹163.43 | +74.1% | Revenue/Share: ₹74.29, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹65.31 | ₹58.78 - ₹71.84 | -23.5% | EBITDA: ₹32.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹82.00 | ₹65.60 - ₹98.40 | -3.9% | CF Growth: 6.4%, Discount: 15% |
ZIMLAB Intrinsic Value vs Market Price — All Valuation Models
Zim Laboratories fair value range ₹65–₹149 vs current market price ₹85.34 across 4 valuation models. Read ZIMLAB dividend payout details for the complete payout history and dividend yield track record.
ZIMLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Zim Laboratories median intrinsic value ₹102.86, current price ₹85.34 — Trading Below Calculated Value by 20.5%, margin of safety 17.0%.
What is the intrinsic value of ZIMLAB?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Zim Laboratories (ZIMLAB) is ₹102.86 (median value). With the current market price of ₹85.34, this represents a +20.5% variance from our estimated fair value.
The valuation range spans from ₹65.31 to ₹148.57, indicating ₹65.31 - ₹148.57.
Is ZIMLAB undervalued or overvalued?
Based on our multi-method analysis, Zim Laboratories (ZIMLAB) appears to be trading below calculated value by approximately 20.5%.
ZIMLAB Financial Health — Key Ratios vs Industry Benchmarks
Zim Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.36 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.77x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ZIMLAB Cash Flow Quality — Operating & Free Cash Flow
Zim Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹41 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹16 Cr | ₹-21 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹38 Cr | ₹20 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹49 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹32 Cr | ₹29 Cr | Positive Free Cash Flow | 8/10 |